A Phase 2 Trial of Hydroxychloroquine in Individuals at Risk for Rheumatoid Arthritis.
Deane KD, Striebich CC, Feser ML, O'Dell JR, James JA, Sparks JA, Davis JM 3rd, Graf J, McMahon MA, Solow EB, Forbess LJ, Tiliakos A, Schiopu E, Danila MI, Horowitz DL, Kay J, Strickland CD, Guthridge JM, Arriens C, Grossman JM, Kristen Demoruelle M, Bemis EA, Frazer-Abel A, Fleischer CL, Fox DA, Mikuls TR, Greenleaf M, York K, Walker S, Keyes-Elstein L, Byron M, Fedler J, Goldmuntz EA, Holers VM.
Deane KD, et al. Among authors: grossman jm.
Arthritis Rheumatol. 2026 Apr;78(4):809-820. doi: 10.1002/art.43366. Epub 2026 Mar 16.
Arthritis Rheumatol. 2026.
PMID: 40884017
Free PMC article.
Clinical Trial.